Leakwise Oil-on-Water Demo Video

Oct 5, 2015 – Boulder, CO – GE Analytical Instruments invites you to view the Leakwise Oil-on-Water Monitoring System demonstration video. In addition to an overview of the new SLC-220 Controller, this video reviews the capablities of various types of Leakwise Sensors for multiple applications and needs, as well as types of communication, and options that are available... Read more

PacBio Sequencing for Human Biomedical Research to be Featured at ASHG Annual Meeting

MENLO PARK, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a pioneer and leader in long-read sequencing using Single Molecule, Real-Time (SMRT®) Technology, today announced that its technology will be featured in 36 presentations at next week’s American Society of Human Genetics (ASHG) 2015 annual meeting taking place in Baltimore,... Read more

Pacific Biosciences Launches New Sequencing Platform Based on Its SMRT Technology

Sequel™ System Offers Significantly Higher Throughput, Reducing Project Costs and TimelinesMENLO PARK, Calif., Sept. 30, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) Technology, today announced it has launched a new nucleic acid sequencing platform. The Sequel™ System provides higher... Read more

Precise Diagnosis for Precision Lung Cancer Drug: GE Healthcare’s Clarient Diagnostics Offering FDA approved PD-L1 companion diagnostic for Merck’s Keytruda®

California, USA – 2 October 2015 –  Clarient Diagnostic Services, Inc. a division of GE Healthcare (NYSE:GE) announced it will be offering the FDA approved PD-L1 companion diagnostic which will help identify patients most likely to benefit from Merck’s newly-approved lung cancer drug, Keytruda.   http://www.genewsroom.com/press-releases/precise-diagnosis-precision-lung-cancer-drug-ge-healthcare%E2%80%99s-clarient-diagnostics Read more

Fujifilm Kyowa Kirin Biologics selects GE’s innovative MabSelect SuRe LX media for biomanufacturing process

Tokyo, Japan and Chalfont St Giles, UK – 7 September 2015 –  GE Healthcare today announced that Fujifilm Kyowa Kirin Biologics has selected GE Healthcare’s innovative MabSelect SuRe™ LX high-affinity chromatography media for the manufacture of monoclonal antibodies. http://www.genewsroom.com/press-releases/fujifilm-kyowa-kirin-biologics-selects-ge%E2%80%99s-innovative-mabselect-sure-lx-media Read more